Alzheimer’s Disease Health System Readiness – The Time to Act is Now
We are at a turning point in our fight against dementia and Alzheimer’s disease. Long-awaited new therapies are on the horizon. To ensure we translate these breakthroughs into results, Europe must prepare.
Alzheimer’s Disease Health System Readiness – The Time to Act is Now
September 21 is World Alzheimer’s Day. Alzheimer’s disease (AD) is the most common form of dementia, affecting around 10 million people in Europe. It has a devastating impact on individuals living with the disease and their families, while threatening to overwhelm health services.
The good news is that a new wave of upcoming innovative medicines holds the potential to deliver several disease-modifying treatments expected to alter the underlying pathology of AD. But European healthcare systems need to plan for this.
In our newly published paper “Alzheimer’s Disease Health System Readiness – The Time to Act is Now”, we urge European leaders to make the fight against AD and other forms of dementia a priority of their healthcare policy. To ensure that we translate these innovative breakthroughs into results, Europe must prepare.
The time for action is now.
The good news is that a new wave of upcoming innovative medicines holds the potential to deliver several disease-modifying treatments expected to alter the underlying pathology of AD. But European healthcare systems need to plan for this.
In our newly published paper “Alzheimer’s Disease Health System Readiness – The Time to Act is Now”, we urge European leaders to make the fight against AD and other forms of dementia a priority of their healthcare policy. To ensure that we translate these innovative breakthroughs into results, Europe must prepare.
The time for action is now.